Single-Incision Gasless Endoscopic Total Thyroidectomy Via Subclavian Approach Versus Open Surgery for PTC

Single-Incision Gasless Endoscopic Total Thyroidectomy Via Subclavian Approach Versus Open Surgery for Papillary Thyroid Carcinoma

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06592755

Enrollment

120

Registered

2024-09-19

Start date

2024-09-20

Completion date

2024-09-30

Last updated

2024-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Papillary Thyroid Carcinoma

Brief summary

Historically, performing a contralateral thyroid lobectomy and lymph node dissection via the subclavian approach was considered challenging. This study aimed to evaluate the safety and feasibility of single-incision gasless endoscopic total thyroidectomy and central compartment neck dissection via the subclavian approach (SCA) in comparison to conventional open surgery for the treatment of papillary thyroid carcinoma (PTC) retrospectively.

Detailed description

Interventions

PROCEDUREsingle-incision, gasless endoscopic total thyroidectomy with central compartment neck dissection

The included patients chose to undergo single-incision, gasless endoscopic total thyroidectomy with central compartment neck dissection via the subclavian approach based on patients preference.

PROCEDUREconventional open surgery

These patients chose to undergo total thyroidectomy with central compartment neck dissection via conventional open surgery based on patients preference.

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 70 Years

Healthy volunteers

Inclusion criteria

* (1) thyroid neoplasm <3.0 cm; * (2) well differentiated papillary thyroid carcinoma.

Exclusion criteria

* (1) extrathyroidal extensions estimated in ultrasonography scan; * (2) enlarged lymph nodes in lateral neck compartment on palpation, or US scan; * (3) suspected distant metastases; * (4) previous history of neck radiation therapy and/or surgery.

Design outcomes

Primary

Measure	Time frame	Description
the disease-free survival	up to 24 months	The disease-free survival refers to the probability of survival without any biologic, structural, or functional events.

Countries

China

Contacts

Primary ContactLin

linpliang3@mail.sysu.edu.cn0086-020-34071439

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026